Clinical and Histopathological Characteristics of Primary and Recurrent Basal Cell Carcinoma: a Retrospective Study of the Patients from a Tertiary Clinical Centre in the Northern Poland

Overview

Journal Postepy Dermatol Alergol

Publisher Termedia

Specialty Allergy & Immunology

Date 2022 Apr 4

PMID 35369621

Authors

Anna Plaszczynska

Robert Skibinski

Martyna Slawinska

Wojciech Biernat

Aleksandra Lesiak

Roman J Nowicki

Michal Sobjanek

Affiliations

Soon will be listed here.

Abstract

Introduction: Basal cell carcinoma (BCC) is the most common malignant neoplasm of the skin. Management of patients with recurrent BCC remains a current clinical issue. Data concerning BCC recurrence rates as well as characteristics of this group of patients in the Polish population are scarce.

Aim: Identification and analysis of clinical, epidemiological and histopathological factors influencing BCC recurrence.

Material And Methods: Histopathological diagnoses of BCC patients treated by surgical methods at the Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, between 2013 and 2018, were retrospectively analysed. The analysis included 1097 tumours diagnosed in 802 patients, of which 1061 were primary BCC (pBCC) and 36 - recurring BCC (rBCC).

Results: In the analysed cohort, rBCCs constituted 3.3% of cases. 49.8% of pBCCs occurred in women; while in the rBCC group - 47.2%. The most common histopathological type was infiltrative BCC, however, it was significantly more prevalent in rBCCs (36.9% and 52.8%, respectively). The average maximum size of pBCC was 12.3 ±8.8 mm, while of rBCC 18.4 ±15.1 mm ( = 0.036). The most common location of both pBCC and rBCC was the nose (tumours in this localization constituted 23.2% and 25.0%, respectively).

Conclusions: In the analysed cohort a relatively low percentage of rBCC was found. Among analysed risk factors, the most important ones were the infiltrative histopathological type of BCC and the non-radical treatment of the primary tumour.

References

Ghanadan A, Abbasi A, Rabet M, Abdollahi P, Abbasi M . Characteristics of Mixed Type Basal Cell Carcinoma in Comparison to Other BCC Subtypes. Indian J Dermatol. 2014; 59(1):56-9. PMC: 3884929. DOI: 10.4103/0019-5154.123496. View

Boulinguez S, Grison-Tabone C, Lamant L, Valmary S, Viraben R, Bonnetblanc J . Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol. 2004; 151(3):623-6. DOI: 10.1111/j.1365-2133.2004.06135.x. View

Szewczyk M, Pazdrowski J, Danczak-Pazdrowska A, Golusinski P, Majchrzak E, Luczewski L . Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma. Postepy Dermatol Alergol. 2014; 31(3):146-51. PMC: 4112263. DOI: 10.5114/pdia.2014.40959. View

Kazantseva I, Khlebnikova A, Babaev V . Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin. Am J Dermatopathol. 1996; 18(1):35-42. DOI: 10.1097/00000372-199602000-00006. View

Hunt M, Halliday G, Weedon D, Cooke B, Barnetson R . Regression in basal cell carcinoma: an immunohistochemical analysis. Br J Dermatol. 1994; 130(1):1-8. DOI: 10.1111/j.1365-2133.1994.tb06873.x. View

Bartos V, Pokorny D, Zacharova O, Haluska P, Doboszova J, Kullova M . Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions. Acta Dermatovenerol Alp Pannonica Adriat. 2011; 20(2):67-75. View

Pan Z, Lin J, Cheng T, Wu J, Wu W . In vivo reflectance confocal microscopy of Basal cell carcinoma: feasibility of preoperative mapping of cancer margins. Dermatol Surg. 2012; 38(12):1945-50. PMC: 3546396. DOI: 10.1111/j.1524-4725.2012.02587.x. View

Rieger K, Linos E, Egbert B, Swetter S . Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer. J Cutan Pathol. 2009; 37(1):59-67. DOI: 10.1111/j.1600-0560.2009.01340.x. View

Halliday G, Patel A, Hunt M, Tefany F, Barnetson R . Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells. World J Surg. 1995; 19(3):352-8. DOI: 10.1007/BF00299157. View

10.

Griffiths R, Suvarna S, Stone J . Do basal cell carcinomas recur after complete conventional surgical excision?. Br J Plast Surg. 2005; 58(6):795-805. DOI: 10.1016/j.bjps.2005.02.010. View

11.

van Loo E, Mosterd K, Krekels G, Roozeboom M, Ostertag J, Dirksen C . Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014; 50(17):3011-20. DOI: 10.1016/j.ejca.2014.08.018. View

12.

Peris K, Fargnoli M, Garbe C, Kaufmann R, Bastholt L, Basset Seguin N . Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer. 2019; 118:10-34. DOI: 10.1016/j.ejca.2019.06.003. View

13.

Iljin A, Zielinski T, Antoszewski B, Sporny S . Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid. Postepy Dermatol Alergol. 2016; 33(1):42-6. PMC: 4793053. DOI: 10.5114/pdia.2015.48039. View

14.

Nagore E, Grau C, Molinero J, Fortea J . Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol. 2003; 17(2):167-70. DOI: 10.1046/j.1468-3083.2003.00535.x. View

15.

Kumar P, Watson S, Brain A, Davenport P, McWilliam L, Banerjee S . Incomplete excision of basal cell carcinoma: a prospective multicentre audit. Br J Plast Surg. 2003; 55(8):616-22. DOI: 10.1054/bjps.2002.3948. View

16.

Miszczyk J, Charytonowicz M, Debski T, Noszczyk B . Incomplete excision of basal cell carcinoma (BCC) in the head and neck region: to wait, or not to wait?. Postepy Dermatol Alergol. 2018; 34(6):607-611. PMC: 5799764. DOI: 10.5114/ada.2017.72467. View

17.

Yuksel E, Gurel M, Erdemir A, Aksu A, Bagci I, Leblebici C . The reflectance confocal microscopy in diagnosis of recurrent basal cell carcinoma. J Dermatolog Treat. 2015; 27(2):182-90. DOI: 10.3109/09546634.2015.1087460. View

18.

Caresana G, Giardini R . Dermoscopy-guided surgery in basal cell carcinoma. J Eur Acad Dermatol Venereol. 2010; 24(12):1395-9. DOI: 10.1111/j.1468-3083.2010.03652.x. View

19.

Kamyab-Hesari K, Seirafi H, Naraghi Z, Shahshahani M, Rahbar Z, Damavandi M . Diagnostic accuracy of punch biopsy in subtyping basal cell carcinoma. J Eur Acad Dermatol Venereol. 2012; 28(2):250-3. DOI: 10.1111/j.1468-3083.2012.04695.x. View

20.

Cohen P, Schulze K, Nelson B . Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol Surg. 2006; 32(4):542-51. DOI: 10.1111/j.1524-4725.2006.32110.x. View